AAAAAA

   
Results: 1-8 |
Results: 8
PRELIMINARY-RESULTS OF NEOADJUVANT PACLITAXEL AND CARBOPLATIN IN THE TREATMENT OF EARLY-STAGE NONSMALL CELL LUNG-CANCER
Authors: PALACKDHARRY CS DURHAM SJ DURZINSKY DS VELTRI S
Citation: Cs. Palackdharry et al., PRELIMINARY-RESULTS OF NEOADJUVANT PACLITAXEL AND CARBOPLATIN IN THE TREATMENT OF EARLY-STAGE NONSMALL CELL LUNG-CANCER, Seminars in oncology, 24(4), 1997, pp. 34-36
PHASE-I TRIAL OF DOSE-ESCALATED PACLITAXEL AND CARBOPLATIN IN COMBINATION WITH IFOSFAMIDE AND FILGRASTIM - PRELIMINARY-RESULTS
Authors: PALACKDHARRY CS
Citation: Cs. Palackdharry, PHASE-I TRIAL OF DOSE-ESCALATED PACLITAXEL AND CARBOPLATIN IN COMBINATION WITH IFOSFAMIDE AND FILGRASTIM - PRELIMINARY-RESULTS, Seminars in oncology, 24(1), 1997, pp. 108-112
COMMON CANCERS - IMMUNOTHERAPY AND MULTIDISCIPLINARY THERAPY .3. IMMUNOTHERAPY FOR CANCER - HARNESSING THE HOST IMMUNE DEFENSES - BIOLOGIC MECHANISMS AND RESULTS IN MELANOMA AND RENAL CELL CARCINOMA .4. MULTIDISCIPLINARY THERAPY OF BREAST, COLORECTAL, AND LUNG CANCER
Authors: SKEEL RT QUAN WDY PALACKDHARRY CS
Citation: Rt. Skeel et al., COMMON CANCERS - IMMUNOTHERAPY AND MULTIDISCIPLINARY THERAPY .3. IMMUNOTHERAPY FOR CANCER - HARNESSING THE HOST IMMUNE DEFENSES - BIOLOGIC MECHANISMS AND RESULTS IN MELANOMA AND RENAL CELL CARCINOMA .4. MULTIDISCIPLINARY THERAPY OF BREAST, COLORECTAL, AND LUNG CANCER, Disease-a-month, 43(11), 1997, pp. 750-808
PHASE-I TRIAL OF DOSE-ESCALATED PACLITAXEL AND CARBOPLATIN IN COMBINATION WITH IFOSFAMIDE AND FILGRASTIM - PRELIMINARY-RESULTS
Authors: PALACKDHARRY CS
Citation: Cs. Palackdharry, PHASE-I TRIAL OF DOSE-ESCALATED PACLITAXEL AND CARBOPLATIN IN COMBINATION WITH IFOSFAMIDE AND FILGRASTIM - PRELIMINARY-RESULTS, Seminars in oncology, 23(3), 1996, pp. 78-83
DOSE SCHEDULING OF IFOSFAMIDE - DISCUSSION
Authors: MARKMAN M GOREN MP DEMETRI GD THIGPEN T NICHOLS CR ETTINGER DS CHANG AY VOSE JM OVERMOYER BA PRATT CB ROTH BJ PALACKDHARRY CS
Citation: M. Markman et al., DOSE SCHEDULING OF IFOSFAMIDE - DISCUSSION, Seminars in oncology, 23(3), 1996, pp. 99-102
NEUROTOXICITY OF IFOSFAMIDE THERAPY - DISCUSSION
Authors: MARKMAN M ETTINGER DS THIGPEN T NICHOLS CR CHANG AY DEMETRI GD VOSE JM PALACKDHARRY CS
Citation: M. Markman et al., NEUROTOXICITY OF IFOSFAMIDE THERAPY - DISCUSSION, Seminars in oncology, 23(3), 1996, pp. 103-104
IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR - A PHASE-I STUDY WITH APPARENT ACTIVITY IN NON-SMALL-CELL LUNG-CANCER
Authors: KRIGEL RL PALACKDHARRY CS PADAVIC K HAAS N KILPATRICK D LANGER C COMIS R
Citation: Rl. Krigel et al., IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR - A PHASE-I STUDY WITH APPARENT ACTIVITY IN NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 12(6), 1994, pp. 1251-1258
DOSE-INTENSIVE IFOSFAMIDE CARBOPLATIN/ETOPOSIDE PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOR NONSMALL CELL LUNG-CANCER/
Authors: PALACKDHARRY CS KRIGEL RL
Citation: Cs. Palackdharry et Rl. Krigel, DOSE-INTENSIVE IFOSFAMIDE CARBOPLATIN/ETOPOSIDE PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOR NONSMALL CELL LUNG-CANCER/, Seminars in oncology, 21(3), 1994, pp. 6-11
Risultati: 1-8 |